Is Aurinia Pharmaceuticals Inc. (AUPH) a Buy, Sell, or Hold?
NASDAQ : AUPH
Aurinia Pharmaceuticals Inc. — Institutional Ownership
$14.88 USD
-$0.12 (-0.8%)
- Volume
- 1.65M
- Average Volume
- 1.49M
- Market Capitalization
- $1.91B
- P/E Ratio
- 6.64
- Dividend Yield
- 0.00%
- Price Target
- $13.00
- Year High
- $19.25
- Year Low
- $10.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.55
Institutional Ownership Summary
Institutional Ownership %
1.21%
Investors Holding
64
change: -211 | last: 275
Increased Positions
31
change: -112 | last: 143
Reduced Positions
12
change: -59 | last: 71
New Positions
11
change: -29 | last: 40
Sold Positions
208
change: 169 | last: 39
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -80.3171 | last: 0.8032
Total Invested
27.08M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-04 | TANG CAPITAL PARTNERS IV, INC | 274.81K | 0.20% |
| 2026-06-04 | TANG CAPITAL MANAGEMENT, LLC | 13.04M | 10.00% |
| 2026-06-04 | KEVIN TANG | 13.04M | 10.00% |
| 2026-06-04 | TANG CAPITAL PARTNERS, LP | 7.21M | 5.60% |
| 2026-06-04 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 5.24M | 4.00% |
| 2026-06-04 | TANG CAPITAL PARTNERS III, INC | 324.81K | 0.20% |
| 2026-03-25 | TANG CAPITAL PARTNERS IV, INC | - | 0.00% |
| 2026-03-25 | TANG CAPITAL MANAGEMENT, LLC | 12.23M | 9.20% |
| 2026-03-25 | KEVIN TANG | 12.23M | 9.20% |
| 2026-03-25 | TANG CAPITAL PARTNERS, LP | 6.99M | 5.30% |
| 2026-03-25 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 5.24M | 3.90% |
| 2026-03-25 | TANG CAPITAL PARTNERS III, INC | - | 0.00% |
| 2026-03-03 | TANG CAPITAL PARTNERS III, INC | - | 0.00% |
| 2026-03-03 | TANG CAPITAL MANAGEMENT, LLC | 12.23M | 9.20% |
| 2026-03-03 | KEVIN TANG | 12.23M | 9.20% |
| 2026-03-03 | TANG CAPITAL PARTNERS, LP | 6.99M | 5.30% |
| 2026-03-03 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 5.24M | 3.90% |
| 2026-03-03 | TANG CAPITAL PARTNERS IV, INC | - | 0.00% |
| 2025-08-13 | Chin Kyu Huh | 6.54M | 5.00% |
| 2025-08-13 | Seoung Eun Huh | 392.19K | 0.30% |
| 2025-08-13 | Sae Kyoung Huh | 465.77K | 0.40% |
| 2025-08-13 | ILJIN GLS Co., Ltd. | 5.41M | 4.10% |
| 2025-08-13 | ILJIN Steel Co., Ltd. | 1.12M | 0.90% |
| 2025-08-13 | ILJIN SNT Co., Ltd. | 5.41M | 4.10% |
| 2025-03-04 | TANG CAPITAL MANAGEMENT, LLC | 10.03M | 7.30% |
| 2025-03-04 | KEVIN TANG | 10.03M | 7.30% |
| 2025-03-04 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 4.39M | 3.20% |
| 2025-03-04 | TANG CAPITAL PARTNERS III, INC | 500K | 0.40% |
| 2025-03-04 | TANG CAPITAL PARTNERS IV, INC | - | 0.00% |
| 2025-03-04 | TANG CAPITAL PARTNERS, LP | 5.14M | 3.70% |
| 2025-02-14 | Armistice Capital, LLC | 6.4M | 4.47% |
| 2024-09-12 | TANG CAPITAL PARTNERS IV, INC | - | 0.00% |
| 2024-09-12 | TANG CAPITAL PARTNERS III, INC | 500K | 0.40% |
| 2024-09-12 | TANG CAPITAL MANAGEMENT, LLC | 7.23M | 5.10% |
| 2024-09-12 | TANG CAPITAL PARTNERS, LP | 6.73M | 4.70% |
| 2024-09-12 | KEVIN TANG | 7.23M | 5.10% |
| 2024-02-14 | Armistice Capital, LLC | 9.54M | 6.64% |
| 2024-02-14 | Steven Boyd | 9.54M | 6.64% |
| 2022-10-28 | Deep Track Biotechnology Master Fund, Ltd. | 7.84M | 5.53% |
| 2022-10-28 | Deep Track Capital, LP | 7.84M | 5.53% |
| 2022-10-28 | David Kroin | 7.84M | 5.53% |
| 2022-02-14 | HealthCor Management, L.P. | - | 0.00% |
| 2021-02-17 | Consonance Capman GP LLC | - | 0.00% |
| 2021-02-17 | Mitchell Blutt | - | 0.00% |
| 2021-02-17 | Consonance Capital Management LP | - | 0.00% |
| 2021-02-17 | Consonance Capital Opportunity Fund Management LP | - | 0.00% |
| 2021-02-16 | Consonance Capital Management LP | - | 0.00% |
| 2021-02-16 | Consonance Capman GP LLC | 6.06M | 9.99% |
| 2021-02-16 | Consonance Capital Opportunity Fund Management LP | 1.19M | 2.04% |
| 2021-02-16 | Mitchell Blutt | 6.06M | 9.99% |
| 2021-02-12 | Joseph Healey | 6.94M | 5.50% |
| 2021-02-12 | HealthCor Sanatate Offshore Master Fund, L.P. | 2.05M | 1.60% |
| 2021-02-12 | HealthCor Offshore II GP, LLC | 2.05M | 1.60% |
| 2021-02-12 | HealthCor Therapeutics Master Fund, L.P. | 70330.0 | 0.10% |
| 2021-02-12 | HealthCor Therapeutics GP, LLC | 70330.0 | 0.10% |
| 2021-02-12 | HealthCor Offshore Master Fund, L.P. | 953.76K | 0.80% |
| 2021-02-12 | HealthCor Offshore GP, LLC | 953.76K | 0.80% |
| 2021-02-12 | HealthCor Group, LLC | 3.07M | 2.40% |
| 2021-02-12 | Arthur Cohen | 6.94M | 5.50% |
| 2021-02-12 | HealthCor Management, L.P. | 6.94M | 5.50% |
| 2021-02-12 | HealthCor Associates, LLC | 6.94M | 5.50% |
| 2020-02-14 | Mitchell Blutt | 6.63M | 3.48% |
| 2020-02-14 | Consonance Capital Opportunity Fund Management LP | 490.03K | 0.24% |
| 2020-02-14 | Consonance Capman GP LLC | 6.63M | 3.48% |
| 2020-02-14 | Consonance Capital Management LP | 6.14M | 3.24% |
| 2020-02-13 | Vivo Capital IX, LLC | 623.43K | 0.60% |
| 2020-02-13 | Vivo Opportunity, LLC | 2.94M | 2.80% |
| 2020-02-13 | Vivo Capital VIII, LLC | 1.07M | 1.00% |
| 2020-02-07 | FMR LLC | 8.03M | 7.50% |
| 2020-01-27 | HealthCor Market Neutral Master Fund, L.P. | 20000.0 | 0.00% |
| 2020-01-27 | HealthCor Market Neutral GP, LLC | 20000.0 | 0.00% |
| 2020-01-27 | HealthCor Offshore GP, LLC | 1.5M | 1.40% |
| 2020-01-27 | HealthCor Offshore II GP, LLC | 1.58M | 1.50% |
| 2020-01-27 | HealthCor Management, L.P. | 5.82M | 5.40% |
| 2020-01-27 | HealthCor Associates, LLC | 5.82M | 5.40% |
| 2020-01-27 | HealthCor Offshore Master Fund, L.P. | 1.5M | 1.40% |
| 2020-01-27 | HealthCor Group, LLC | 3.1M | 2.90% |
| 2020-01-27 | Arthur Cohen | 5.82M | 5.40% |
| 2020-01-27 | Joseph Healey | 5.82M | 5.40% |
| 2020-01-27 | HealthCor Sanatate Offshore Master Fund, L.P. | 1.58M | 1.50% |
| 2019-09-25 | Vivo Opportunity, LLC | 2.86M | 3.10% |
| 2019-09-25 | Vivo Capital IX, LLC | 600.36K | 0.70% |
| 2019-09-25 | Vivo Capital VIII, LLC | 1.29M | 1.40% |
| 2017-04-06 | Lumira Capital II, L.P. | 2.69M | 4.37% |
| 2017-04-06 | Benjamin Rovinski | 2.93M | 4.77% |
| 2017-04-06 | Lumira GP Inc. | 2.93M | 4.77% |
| 2017-04-06 | Lumira GP Holdings Co. | 2.93M | 4.77% |
| 2017-04-06 | Lumira Capital GP, L.P. | 2.93M | 4.77% |
| 2017-04-06 | Lumira Capital II (International), L.P. | 248.36K | 0.41% |
| 2017-04-06 | Lumira Capital Investment Management Inc. | 2.93M | 4.77% |
| 2017-02-14 | Great Point Partners, LLC | - | 0.00% |
| 2017-02-14 | Mr. David Kroin | - | 0.00% |
| 2017-02-14 | Dr. Jeffrey R. Jay, M.D. | - | 0.00% |
| 2017-01-05 | ILJIN SNT Co., Ltd. | 9.02M | 16.64% |
| 2017-01-05 | ILJIN Life Science Co., Ltd. | 4.73M | 8.94% |
| 2017-01-05 | Chin Kyu Huh | 9.02M | 16.64% |
| 2016-07-05 | Chin Kyu Huh | 7.02M | 19.31% |
| 2016-07-05 | ILJIN SNT Co., Ltd. | 7.02M | 19.31% |
| 2016-07-05 | ILJIN Life Science Co., Ltd. | 4.73M | 13.23% |
| 2016-02-16 | RA Capital Management, LLC | 618.52K | 1.90% |
| 2016-02-16 | Redmile Group, LLC | 2.86M | 8.87% |
| 2016-02-16 | Great Point Partners, LLC | 3.08M | 9.53% |
| 2016-02-16 | JEREMY C. GREEN | 2.86M | 8.87% |
| 2016-02-16 | Mr. David Kroin | 3.08M | 9.53% |
| 2016-02-16 | Dr. Jeffrey R. Jay, M.D. | 3.08M | 9.53% |
| 2015-03-25 | RA Capital Healthcare Fund, L.P. | 2.6M | 8.20% |
| 2015-03-25 | RA Capital Management, LLC | 3.09M | 9.70% |
| 2015-03-25 | Peter Kolchinsky | 3.09M | 9.70% |
| 2015-02-17 | Seung-Gwon Park | 4.73M | 20.80% |
| 2015-02-17 | Chin-Kyu Huh. | 4.73M | 20.80% |
| 2015-02-17 | Sang-Dong Kim | 4.73M | 20.80% |
| 2015-02-17 | ILJIN Life Science Co., Ltd. | 4.73M | 20.80% |
| 2015-02-12 | Paul Brooke | 6.82M | 20.60% |
| 2015-02-12 | Robert Adelman | 6.82M | 20.60% |
| 2015-02-12 | venBio Global Strategic GP, Ltd. | 6.82M | 20.60% |
| 2015-02-12 | venBio Global Strategic GP, L.P. | 6.82M | 20.60% |
| 2015-02-12 | venBio Global Strategic Fund, L.P. | 6.82M | 20.60% |
| 2015-02-12 | Corey Goodman | 6.82M | 20.60% |
| 2015-02-11 | Ravi Viswanathan | 3.18M | 9.80% |
| 2015-02-11 | Patrick J. Kerins | 3.18M | 9.80% |
| 2015-02-11 | Anthony A. Florence, Jr. | 3.18M | 9.80% |
| 2015-02-11 | Peter J. Barris | 3.18M | 9.80% |
| 2015-02-11 | New Enterprise Associates 14, L.P. | 3.18M | 9.80% |
| 2015-02-11 | Harry R. Weller | 3.18M | 9.80% |
| 2015-02-11 | Growth Equity Opportunities Fund III, LLC | 3.18M | 9.80% |
| 2015-02-11 | Peter W. Sonsini | 3.18M | 9.80% |
| 2015-02-11 | NEA Partners 14, L.P. | 3.18M | 9.80% |
| 2015-02-11 | NEA 14 GP, LTD | 3.18M | 9.80% |
| 2015-02-11 | Forest Baskett | 3.18M | 9.80% |
| 2015-02-11 | Ryan D. Drant | 3.18M | 9.80% |
| 2015-02-11 | Krishna S. Kolluri | 3.18M | 9.80% |
| 2015-02-11 | David M. Mott | 3.18M | 9.80% |
| 2015-02-11 | Scott D. Sandell | 3.18M | 9.80% |
| 2015-02-11 | Michael James Barrett | 3.18M | 9.80% |
AUPH Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $15.95 | 134.37M | $2.14B | $80.21M | $74.81M | $2.14B |
| 2024-12-31 | $8.98 | 143.06M | $1.28B | $83.43M | $79.37M | $1.28B |
| 2023-12-31 | $8.99 | 143.24M | $1.29B | $48.88M | $97.61M | $1.34B |
| 2022-12-31 | $4.32 | 141.92M | $613.07M | $94.17M | $8.09M | $526.99M |
| 2021-12-31 | $22.87 | 129.37M | $2.96B | $231.9M | $8.74M | $2.74B |
| 2020-12-31 | $13.83 | 118.47M | $1.64B | $272.35M | $8.41M | $1.37B |
| 2019-12-31 | $20.26 | 93.02M | $1.88B | $306.02M | -$ | $1.58B |
| 2018-12-31 | $6.82 | 84.78M | $578.21M | $117.97M | -$ | $460.25M |
| 2017-12-31 | $4.85 | 76.92M | $373.05M | $165.63M | -$ | $207.42M |
| 2016-12-31 | $2.10 | 35.28M | $74.1M | $39.65M | -$ | $34.45M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14.82 | 132.38M | $1.96B | $41.01M | $68.64M | $1.99B |
| 2025-12-31 | $15.95 | 134.37M | $2.14B | $80.21M | $74.81M | $2.14B |
| 2025-09-30 | $11.05 | 137.18M | $1.52B | $73.19M | $78.21M | $1.52B |
| 2025-06-30 | $8.47 | 138.92M | $1.18B | $53M | $81.83M | $1.21B |
| 2025-03-31 | $8.04 | 138.92M | $1.12B | $66.43M | $77.91M | $1.13B |
| 2024-12-31 | $8.98 | 142.18M | $1.28B | $83.43M | $79.37M | $1.27B |
| 2024-09-30 | $7.33 | 143.05M | $1.05B | $37.14M | $87.85M | $1.1B |
| 2024-06-30 | $5.49 | 143.33M | $786.87M | $33.41M | $85.98M | $839.44M |
| 2024-03-31 | $5.40 | 144.01M | $777.67M | $64.46M | $88.54M | $801.75M |
| 2023-12-31 | $8.99 | 143.62M | $1.29B | $48.88M | $97.61M | $1.34B |
| 2023-09-30 | $7.77 | 142.85M | $1.11B | $46.4M | $93.21M | $1.16B |
| 2023-06-30 | $9.68 | 142.78M | $1.38B | $81.71M | $101.21M | $1.4B |